CGEM peer analysis
Cullinan Therapeutics (CGEM) against its competitors: price, today's move, 1-year return and market value side by side.
CGEM and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ADCT ADC Therapeutics | $1.65 | 4.43% | -60.34% | $210.65M |
| ALXO ALX Oncology | $1.23 | 6.49% | 4.24% | $170.08M |
| AVBP ArriVent BioPharma | $14.16 | 3.81% | -23.00% | $698.20M |
| CGEN Compugen | $1.96 | 2.08% | 19.51% | $185.67M |
| IMTX Immatics | $6.42 | 1.02% | -30.39% | – |
| JANX Janux | $12.76 | -27.62% | -55.48% | $780.70M |
| LEGN Legend Biotech | $24.32 | 3.93% | -24.87% | $4.71B |
| MGNX MacroGenics | $2.33 | 0.21% | 71.69% | $148.74M |
| NRIX Nurix Therapeutics | $16.13 | 5.42% | 28.83% | $1.76B |
| XNCR Xencor | $38.58 | 7.92% | 175.57% | $2.90B |
| CGEM Cullinan Therapeutics | $11.70 | 3.45% | 59.18% | $752.95M |
- CGEM's peers: ADCT (ADC Therapeutics), ALXO (ALX Oncology), AVBP (ArriVent BioPharma), CGEN (Compugen), IMTX (Immatics), JANX (Janux), LEGN (Legend Biotech), MGNX (MacroGenics).
Updated 2026-11-10 04:46 UTC